VCP/p97 inhibitor CB-5083 modulates muscle pathology in a mouse model of VCP inclusion body myopathy.

J Transl Med · 2022 · PMC8742393 · PMID 34998409

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

Despite the variation of biomarker expression with CB-5083 treatment, we found a slight trend towards reduced p62, LC3I/II, and TFEB levels (Fig. 6 ).

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.